Valproate (Epilim) – Potential risk of NDD in children of fathers treated with valproate
19/02/2024
Medicines for human use
Direct healthcare professional communication (DHPC)
Valproate - containing medicines: new measures regarding the potential risk of neurodevelopmental disorders in children of fathers treated with valproate in the 3 months prior to conception